NCT05655858

Brief Summary

Observational, cross-sectional, prospective, multicentric study in France with private paediatricians to describe the management of allergic rhinitis in children.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,004

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 23, 2022

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

December 1, 2022

Completed
18 days until next milestone

First Posted

Study publicly available on registry

December 19, 2022

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 3, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 3, 2024

Completed
Last Updated

October 3, 2025

Status Verified

September 1, 2025

Enrollment Period

1.3 years

First QC Date

December 1, 2022

Last Update Submit

September 30, 2025

Conditions

Allergic Rhinitis

Outcome Measures

Primary Outcomes (1)

  • Proportion of children over 2 years of age with allergic rhinitis eligible for allergic immunotherapy

    Descriptive analysis : evaluation with data collected in the case report form about allergic rhinitis

    1 year

Interventions

Management of allergic rhinitisOTHER

Collection of patient data in real-life

Eligibility Criteria

Age2 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

1000 patients aged 2 to 18 years old with allergic rhinitis

You may qualify if:

  • Under 18 years of age
  • With allergic rhinitis
  • Who's representative of the parental authority did not object to his child's participation after oral and written information and who agrees to participate

You may not qualify if:

  • Child or adolescent opposed to participate or collect his personal data

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital Necker-Enfants malades - AP-HP Service de Pneumologie et Allergologie Pédiatriques

Paris, 75015, France

Location

MeSH Terms

Conditions

Rhinitis, Allergic

Condition Hierarchy (Ancestors)

RhinitisNose DiseasesRespiratory Tract DiseasesRespiratory HypersensitivityOtorhinolaryngologic DiseasesHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 1, 2022

First Posted

December 19, 2022

Study Start

November 23, 2022

Primary Completion

March 3, 2024

Study Completion

March 3, 2024

Last Updated

October 3, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations

FR(1)